Information
Learning Objective 1
Explore complex drug-drug interactions, cost effectiveness, and practical considerations with the use of newer anti-seizure medications (such as fenfluramine, cenobamate, cannabidiol, and stiripentol)
Learning Objective 2
Learn how to assess risks and benefits of complementary and alternative medications and determine when they may or may not be appropriate for a patient
Learning Objective 3
Discuss the rational concurrent use of multiple anti-seizure medications with emphasis on side effects, use in specific epilepsy syndromes, and implications for lower resource settings
Target Audience
CliniciansFellows/TraineesAdvanced Practice Providers (APPs)NursesPharmacistsScientists/Researchers
Career Stage
Early Career (typically 0-5 years from completion of training)Mid-Career (typically 6-15 years from completion of trainingSenior (typically >15 years from completion of training)
Demographics
ClinicalYoung ProfessionalsResearchFirst-time Attendee
Session Content Includes
and Inclusion (DEI)DiversityEquityPatient PerspectivePediatric
Session ID
NEUROPHARMSIG26
Presentation Id
3452247
Event ID
24056
Session Type
Session

